KamiJ.MaddocksMD
Hematology • Columbus, OHAssistant Professor, Internal Medicine, Ohio State University College of Medicine
Dr. Maddocks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
460 W 10th Ave
5th Floor
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812- Is this information wrong?
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2005 - 2008
University of South Dakota, Sanford School of MedicineClass of 2005
Certifications & Licensure
OH State Medical License 2008 - 2024
MN State Medical License 2006 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma Start of enrollment: 2011 Dec 07
- IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia Start of enrollment: 2012 Jan 01
- PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia Start of enrollment: 2012 May 21
- Join now to see all
Publications & Presentations
PubMed
- Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Yi Wang, Kelsi Reynolds, Robert Bolz, Jessica Miao, Chunhua Song, Dayong Wu, Wing Keun...> ;Blood Advances. 2024 Mar 23
- 7 citationsTafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha Merrill, Priyanka Pullarkat, Richard C Godby, David A Bond, Graham T Wehmeyer, Jason Romancik, Behzad Amoozga...> ;Blood. 2023 Dec 28
- Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.Gerson, J., Handorf, E., Villa, D., Gerrie, A., Chapani, P., Li, S., Medeiros, L., Wang, M., Cohen, J., Churnetski, M., Hill, B., Sawalha, Y., Hernandez-Ilizaliturri, ...> ;Blood Advances. 2023 Dec 26
- Join now to see all
Journal Articles
- Update on Mantle Cell LymphomaKami Maddocks, MD, Blood
Abstracts/Posters
- Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaKami J. Maddocks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...Kami J. Maddocks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin LymphomaKami J. Maddocks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Emerging Paradigms to Address Unmet Needs in Relapsed/Refractory DLBCL61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Update of the single-arm phase II L-MIND study of MOR208 + lenalidomide (LEN) in relapsed/refractory diffuse large B-cell lymphoma (R-R DLBCL): Response rates in patie...2019 ASCO Annual Meeting - 6/1/2019
- Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Comorbidities and Role of R-CHOP in DLBCLFebruary 7th, 2020- Potential Ibrutinib Resistance Mechanisms Identified in CLLMarch 20th, 2015
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
